ALKERAN Side Effects

7012807-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Convulsion, Encephalitis Viral, Febrile Neutropenia, Liver Disorder
on Sep 10, 2010 Female patient from JAPAN , weighting 110.2 lb, was diagnosed with immunosuppression and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, convulsion, encephalitis viral, febrile neutropenia, liver disorder. Alkeran dosage: 40mg Per Day. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), PROGRAF (.8mg Per Day) (View Prograf Review and Prograf Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), VICCLOX (750mg Per Day) (View Vicclox Review and Vicclox Label ), GANCICLOVIR SODIUM (250mg Per Day) (View Ganciclovir Sodium Review and Ganciclovir Sodium Label ), PHENYTOIN SODIUM (250mg Per Day) (View Phenytoin Sodium Review and Phenytoin Sodium Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), GASTER (40mg Per Day) (View Gaster Review and Gaster Label ). Patient was hospitalized and became disabled.

6992861-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Febrile Neutropenia, Herpes Zoster, Liver Disorder, Pyrexia
Patient was taking Alkeran (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, febrile neutropenia, herpes zoster, liver disorder, pyrexia on Sep 10, 2010 from JAPAN Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with stem cell transplant and. Alkeran dosage: 100mg Per Day. During the same period patient was treated with BAKTAR (4iuax Per Day) (View Baktar Review and Baktar Label ), CIPROXAN (600mg Per Day) (View Ciproxan Review and Ciproxan Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), FAMOTIDINE (20mg Per Day) (View Famotidine Review and Famotidine Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), FUNGUARD (150mg Per Day) (View Funguard Review and Funguard Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), ACYCLOVIR SODIUM (1.25g Per Day) (View Acyclovir Sodium Review and Acyclovir Sodium Label ). Patient was hospitalized.

6985503-8 | Sepsis
Adverse event was reported on Sep 09, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: 60mgm2 Per Day) was diagnosed with immunosuppression and. Location: JAPAN , weighting 123.5 lb, After Alkeran was administered, patient had the following side effects: sepsis (What is sepsis?). During the same period patient was treated with FLUDARA (30mgm2 Per Day) (View Fludara Review and Fludara Label ), GRAN (View Gran Review and Gran Label ), CYCLOSPORINE (100mg Per Day) (View Cyclosporine Review and Cyclosporine Label ), METHOTREXATE (15mg Per Day) (View Methotrexate Review and Methotrexate Label ), MEROPEN (.5g Per Day) (View Meropen Review and Meropen Label ), VANCOMYCIN (.5g Per Day) (View Vancomycin Review and Vancomycin Label ).

6985499-9 | Circulatory Collapse, Thrombotic Microangiopathy
on Sep 08, 2010 Male patient from JAPAN , weighting 26.01 lb, was diagnosed with immunosuppression and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, thrombotic microangiopathy. Alkeran dosage: 50mgm2 Per Day. During the same period patient was treated with TACROLIMUS (.24mg Per Day) (View Tacrolimus Review and Tacrolimus Label ), METHOTREXATE (8.4mg Per Day) (View Methotrexate Review and Methotrexate Label ), FUROSEMIDE (5mg Per Day) (View Furosemide Review and Furosemide Label ), FLUDARA (17mgm2 Per Day) (View Fludara Review and Fludara Label ), GRAN (View Gran Review and Gran Label ), FRAGMIN (900iu Per Day) (View Fragmin Review and Fragmin Label ), VICCLOX (125mg Per Day) (View Vicclox Review and Vicclox Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (2.5g Per Day) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.


6980997-6 | C-reactive Protein Increased, Diarrhoea, Gamma-glutamyltransferase Increased, Stomatitis
on Sep 07, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). Patient had the following side effects: c-reactive protein increased, diarrhoea, gamma-glutamyltransferase increased, stomatitis. Alkeran dosage: 140mgm2 Per Day. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), PARIET (20mg Per Day) (View Pariet Review and Pariet Label ), ALOSITOL (300mg Per Day) (View Alositol Review and Alositol Label ), DIFLUCAN (100mg Per Day) (View Diflucan Review and Diflucan Label ), BACTRAMIN (1iuax Per Day) (View Bactramin Review and Bactramin Label ), MUCOSTA (300mg Per Day) (View Mucosta Review and Mucosta Label ), GRANISETRON HCL (3mg Per Day) (View Granisetron Hcl Review and Granisetron Hcl Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (5g Per Day) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

6980994-0 | Haemorrhage, Neutrophil Count Decreased, Pain, Stomatitis
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: haemorrhage, neutrophil count decreased, pain (What is pain?), stomatitis on Sep 06, 2010 from JAPAN Additional patient health information: Male patient , 50 years of age, . Alkeran dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), POLAPREZINC (View Polaprezinc Review and Polaprezinc Label ).

6980929-0 | Myoclonus
Adverse event was reported on Sep 08, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 1inj Single Dose) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: myoclonus. Patient was hospitalized and became disabled.

6980927-7 | Myoclonus
on Sep 08, 2010 Female patient from UNITED STATES , 68 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: myoclonus. Alkeran dosage: 1inj Single Dose. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized and became disabled.

6980925-3 | Myoclonus
on Sep 08, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: myoclonus. Alkeran dosage: 1inj Single Dose. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized and became disabled.

6976886-3 | Myoclonic Epilepsy
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: myoclonic epilepsy on Sep 03, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with stem cell transplant, multiple myeloma (What is multiple myeloma?) and. Alkeran dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6958338-X | Hepatitis B, Liver Injury
Adverse event was reported on Aug 23, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 200mgm2 Per Day) . Location: JAPAN , 59 years of age, Patient had the following side effects: hepatitis b (What is hepatitis b?), liver injury. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6958337-8 | Hepatitis B
on Aug 23, 2010 Female patient from JAPAN , 61 years of age, was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). Alkeran dosage: 200mgm2 Per Day.

6934424-5 | Cytomegalovirus Infection, Febrile Neutropenia
on Aug 13, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with immunosuppression and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), febrile neutropenia. Alkeran dosage: 40mg Per Day. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), CYCLOSPORINE (200mg Per Day) (View Cyclosporine Review and Cyclosporine Label ), GRAN (View Gran Review and Gran Label ). Patient was hospitalized.

6934327-6 | Anaemia, Dizziness, Gastrointestinal Haemorrhage, Hypertrophic Cardiomyopathy, Hypotension
Patient was taking Alkeran (View Usage). Patient had the following side effects: anaemia, dizziness (What is dizziness?), gastrointestinal haemorrhage, hypertrophic cardiomyopathy, hypotension on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Alkeran dosage: 18mg Per Day. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6900989-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Convulsion, Encephalitis Viral, Febrile Neutropenia, Liver Disorder
Adverse event was reported on Jul 27, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 40mg Per Day) was diagnosed with immunosuppression and. Location: JAPAN , weighting 110.2 lb, After Alkeran was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, convulsion, encephalitis viral, febrile neutropenia, liver disorder. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), PROGRAF (.8mg Per Day) (View Prograf Review and Prograf Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), VICCLOX (750mg Per Day) (View Vicclox Review and Vicclox Label ), GANCICLOVIR (250mg Per Day) (View Ganciclovir Review and Ganciclovir Label ), PHENYTOIN SODIUM (250mg Per Day) (View Phenytoin Sodium Review and Phenytoin Sodium Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), GASTER (40mg Per Day) (View Gaster Review and Gaster Label ). Patient was hospitalized and became disabled.

6900975-2 | Abdominal Pain Upper, Blood Albumin Decreased, C-reactive Protein Increased, Coagulation Test Abnormal, Condition Aggravated, Disseminated Intravascular Coagulation, Fibrin Degradation Products Increased, Haemoglobin Decreased, Platelet Count Decreased
on Jul 23, 2010 Female patient from JAPAN , weighting 97.00 lb, was diagnosed with infection (What is infection?), prophylaxis against transplant rejection, nausea (What is nausea?) and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood albumin decreased, c-reactive protein increased, coagulation test abnormal, condition aggravated, disseminated intravascular coagulation, fibrin degradation products increased, haemoglobin decreased, platelet count decreased. Alkeran dosage: 122mg Per Day. During the same period patient was treated with FLUDARA (33mg Per Day) (View Fludara Review and Fludara Label ), FIRSTCIN (4mg Per Day) (View Firstcin Review and Firstcin Label ), GLEEVEC (600mg Per Day) (View Gleevec Review and Gleevec Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), KYTRIL (6mg Per Day) (View Kytril Review and Kytril Label ), GASTER (View Gaster Review and Gaster Label ). Patient was hospitalized and became disabled.

6896299-2 | Febrile Neutropenia, Herpes Zoster
on Jul 27, 2010 Female patient from JAPAN , weighting 138.9 lb, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). Patient had the following side effects: febrile neutropenia, herpes zoster. Alkeran dosage: 100mg Per Day. During the same period patient was treated with COTRIM (4iuax Per Day) (View Cotrim Review and Cotrim Label ), CIPROFLOXACIN HCL (600mg Per Day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), FAMOTIDINE (20mg Per Day) (View Famotidine Review and Famotidine Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), FUNGUARD (150mg Per Day) (View Funguard Review and Funguard Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), ACYCLOVIR (1.25g Per Day) (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6896298-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Herpes Zoster, Myeloma Recurrence, Rash, Renal Failure
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, herpes zoster, myeloma recurrence, rash (What is rash?), renal failure on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with stem cell transplant and. Alkeran dosage: 100mg Per Day. During the same period patient was treated with COTRIM (4iuax Per Day) (View Cotrim Review and Cotrim Label ), TAKEPRON (30mg Per Day) (View Takepron Review and Takepron Label ), ACYCLOVIR (1.25g Per Day) (View Acyclovir Review and Acyclovir Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), CIPROFLOXACIN HCL (600mg Per Day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), VICCLOX (750mg Per Day) (View Vicclox Review and Vicclox Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), ZOMETA (4mg Per Day) (View Zometa Review and Zometa Label ). Patient was hospitalized.

6896297-9 | Cytomegalovirus Infection, Pyrexia, Sepsis
Adverse event was reported on Jul 27, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 40mg Per Day) was diagnosed with immunosuppression and. Location: JAPAN , weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), pyrexia, sepsis (What is sepsis?). During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), GRAN (View Gran Review and Gran Label ), TACROLIMUS (1.02mg Per Day) (View Tacrolimus Review and Tacrolimus Label ), ADENOSINE (250mg Per Day) (View Adenosine Review and Adenosine Label ), COTRIM (4iuax Per Day) (View Cotrim Review and Cotrim Label ), CIPROFLOXACIN HCL (600mg Per Day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), FULCALIQ (903ml Per Day) (View Fulcaliq Review and Fulcaliq Label ). Patient was hospitalized.

6896296-7 | Cytomegalovirus Infection, Febrile Neutropenia, Immunology Test Abnormal, Liver Disorder
on Jul 27, 2010 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with stem cell transplant, immunosuppression and was treated with Alkeran (View Usage). Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), febrile neutropenia, immunology test abnormal, liver disorder. Alkeran dosage: 90mg Per Day. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), METHOTREXATE (15mg Per Day) (View Methotrexate Review and Methotrexate Label ), GRAN (View Gran Review and Gran Label ), TACROLIMUS (1mg Per Day) (View Tacrolimus Review and Tacrolimus Label ), COTRIM (4iuax Per Day) (View Cotrim Review and Cotrim Label ), CIPROFLOXACIN HCL (600mg Per Day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6896294-3 | Pneumonia
on Jul 27, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with immunosuppression and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: pneumonia (What is pneumonia?). Alkeran dosage: 40mg Per Day. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), IRRADIATION (View Irradiation Review and Irradiation Label ), GRAN (View Gran Review and Gran Label ), CYCLOSPORINE (165mg Per Day) (View Cyclosporine Review and Cyclosporine Label ), ACINON (150mg Per Day) (View Acinon Review and Acinon Label ), CALSLOT (20mg Per Day) (View Calslot Review and Calslot Label ), DIFLUCAN (200mg Per Day) (View Diflucan Review and Diflucan Label ), PRODIF (400mg Per Day) (View Prodif Review and Prodif Label ).

6896293-1 | Pneumonia
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?) on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with immunosuppression and. Alkeran dosage: 40mg Per Day. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), GRAN (View Gran Review and Gran Label ), CYCLOSPORINE (160mg Per Day) (View Cyclosporine Review and Cyclosporine Label ), MEROPEN (2g Per Day) (View Meropen Review and Meropen Label ), MODACIN (4g Per Day) (View Modacin Review and Modacin Label ), FUNGUARD (150mg Per Day) (View Funguard Review and Funguard Label ), VANCOMYCIN (1g Per Day) (View Vancomycin Review and Vancomycin Label ), FULCALIQ (903ml Per Day) (View Fulcaliq Review and Fulcaliq Label ).

6896292-X | Cytomegalovirus Infection, Febrile Neutropenia
Adverse event was reported on Jul 27, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: 40mg Per Day) was diagnosed with immunosuppression and. Location: JAPAN , weighting 121.3 lb, Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), febrile neutropenia. During the same period patient was treated with FLUDARA (25mg Per Day) (View Fludara Review and Fludara Label ), CYCLOSPORINE (200mg Per Day) (View Cyclosporine Review and Cyclosporine Label ), GRAN (View Gran Review and Gran Label ). Patient was hospitalized.

6880502-9 | Anaemia, Dizziness, Gastrointestinal Haemorrhage, Hypertrophic Cardiomyopathy, Hypotension
on Jul 15, 2010 Male patient from UNITED STATES , 71 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: anaemia, dizziness (What is dizziness?), gastrointestinal haemorrhage, hypertrophic cardiomyopathy, hypotension. Alkeran dosage: 18mg Per Day. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6857099-2 | Blood Lactate Dehydrogenase Increased, Brain Stem Infarction, Platelet Count Decreased, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
on Jul 08, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, brain stem infarction, platelet count decreased, renal failure acute, thrombotic thrombocytopenic purpura. Alkeran dosage: . During the same period patient was treated with RANIMUSTINE (View Ranimustine Review and Ranimustine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6836046-3 | Abdominal Pain Upper, Myocardial Infarction
Patient was taking Alkeran (View Usage). Patient had the following side effects: abdominal pain upper, myocardial infarction on Jul 06, 2010 from BELGIUM Additional patient health information: Male patient , weighting 104.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), nausea (What is nausea?), arrhythmia (What is arrhythmia?), prophylaxis and. Alkeran dosage: 10mg Per Day. During the same period patient was treated with THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), OMEPRAZOLE (4mg Per Day) (View Omeprazole Review and Omeprazole Label ), MOTILIUM (View Motilium Review and Motilium Label ), RIOPAN (2400mg Per Day) (View Riopan Review and Riopan Label ), CORDARONE (200mg Per Day) (View Cordarone Review and Cordarone Label ), ASPIRIN (100mg Per Day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6817520-2 | Grand Mal Convulsion, Thrombocytopenia
Adverse event was reported on Jun 24, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: ) was diagnosed with stem cell transplant and. Location: NETHERLANDS , weighting 211.6 lb, After Alkeran was administered, patient had the following side effects: grand mal convulsion, thrombocytopenia. During the same period patient was treated with OSTAC (520mg Per Day) (View Ostac Review and Ostac Label ), PERINDOPRIL (4mg Per Day) (View Perindopril Review and Perindopril Label ).

6817515-9 | Pulmonary Embolism, Pulmonary Infarction
on Jun 25, 2010 Male patient from ITALY , 82 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), antiviral prophylaxis, platelet disorder and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?), pulmonary infarction. Alkeran dosage: 10mg Per Day. During the same period patient was treated with DELTACORTENE (View Deltacortene Review and Deltacortene Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TALAVIR (View Talavir Review and Talavir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6814858-X | Glomerulosclerosis
on Jun 23, 2010 Female patient from JAPAN , 62 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: glomerulosclerosis. Alkeran dosage: .

6814857-8 | Glomerulosclerosis
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: glomerulosclerosis on Jun 23, 2010 from JAPAN Additional patient health information: Male patient , 56 years of age, . Alkeran dosage: .

6812812-5 | Pulmonary Embolism, Pulmonary Infarction
Adverse event was reported on Jun 23, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: 10mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?), antiviral prophylaxis, platelet disorder and. Location: ITALY , 82 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?), pulmonary infarction. During the same period patient was treated with DELTACORTENE (View Deltacortene Review and Deltacortene Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TALAVIR (View Talavir Review and Talavir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6812790-9 | Glomerulosclerosis
on Jun 23, 2010 Male patient from JAPAN , 63 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: glomerulosclerosis. Alkeran dosage: .

6790903-5 | Chorioretinal Atrophy, Eyelid Oedema, Optic Atrophy, Retinal Artery Occlusion, Vitreous Haemorrhage
on Jun 14, 2010 Female patient from JAPAN , child 2 years of age, was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: chorioretinal atrophy, eyelid oedema, optic atrophy, retinal artery occlusion, vitreous haemorrhage. Alkeran dosage: 7.5mgm2 Per Day.

6786488-X | Bronchopulmonary Aspergillosis, Cytomegalovirus Infection
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, cytomegalovirus infection (What is cytomegalovirus infection?) on Jun 16, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with stem cell transplant, febrile neutropenia and. Alkeran dosage: 100mg Per Day. During the same period patient was treated with GRAN (300mcg Per Day) (View Gran Review and Gran Label ), MEROPEN (2g Per Day) (View Meropen Review and Meropen Label ).

6768041-7 | Diarrhoea, Febrile Neutropenia, Melaena, Pericarditis
Adverse event was reported on Jun 04, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: 220mg Per Day) was diagnosed with stem cell transplant and. Location: JAPAN , weighting 123.5 lb, Patient had the following side effects: diarrhoea, febrile neutropenia, melaena, pericarditis. During the same period patient was treated with NEUTROGIN (View Neutrogin Review and Neutrogin Label ), OMEPRAL (20mg Per Day) (View Omepral Review and Omepral Label ), OZEX (150mg Per Day) (View Ozex Review and Ozex Label ), MUCOSTA (200mg Per Day) (View Mucosta Review and Mucosta Label ), ZOVIRAX (400mg Per Day) (View Zovirax Review and Zovirax Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), ACYCLOVIR (125mg Per Day) (View Acyclovir Review and Acyclovir Label ), PHENOBARBITAL TAB (60mg Per Day) (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6758536-4 | Diarrhoea, Febrile Neutropenia, Melaena, Pericarditis
on May 28, 2010 Male patient from JAPAN , weighting 123.5 lb, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: diarrhoea, febrile neutropenia, melaena, pericarditis. Alkeran dosage: 220mg Per Day. During the same period patient was treated with NEUTROGIN (View Neutrogin Review and Neutrogin Label ), OMEPRAL (20mg Per Day) (View Omepral Review and Omepral Label ), OZEX (150mg Per Day) (View Ozex Review and Ozex Label ), MUCOSTA (200mg Per Day) (View Mucosta Review and Mucosta Label ), ZOVIRAX (400mg Per Day) (View Zovirax Review and Zovirax Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), ACYCLOVIR SODIUM (125mg Per Day) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), PHENOBARBITAL TAB (60mg Per Day) (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6750965-8 | Abdominal Pain Upper, Coagulopathy, Disseminated Intravascular Coagulation, Venoocclusive Liver Disease, Weight Increased
on May 14, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, coagulopathy, disseminated intravascular coagulation, venoocclusive liver disease, weight increased. Alkeran dosage: . During the same period patient was treated with FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6740232-0 | Blood Creatinine Increased, Blood Uric Acid Increased
Patient was taking Alkeran (View Usage). Patient had the following side effects: blood creatinine increased, blood uric acid increased on May 18, 2010 from JAPAN Additional patient health information: Female patient , 77 years of age, . Alkeran dosage: 8mg Per Day.

6730440-7 | Diffuse Large B-cell Lymphoma
Adverse event was reported on May 10, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: JAPAN , 67 years of age, After Alkeran was administered, patient had the following side effects: diffuse large b-cell lymphoma. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ).

6730439-0 | Lymphoma
on May 10, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?). Alkeran dosage: .

6705068-5 | Fungal Infection, Haematotoxicity, Infection Susceptibility Increased, Leukopenia, Marasmus, Pancytopenia, Pneumonia
on Apr 26, 2010 Male patient from GERMANY , 69 years of age, weighting 183.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), immunosuppression, cardiac failure, cardiovascular event prophylaxis, osteoporosis (What is osteoporosis?) and was treated with Alkeran (View Usage). Patient had the following side effects: fungal infection (What is fungal infection?), haematotoxicity, infection susceptibility increased, leukopenia, marasmus, pancytopenia, pneumonia (What is pneumonia?). Alkeran dosage: 12.5mg Per Day. During the same period patient was treated with CELLCEPT (500mg Twice Per Day) (View Cellcept Review and Cellcept Label ), SANDIMMUNE (75mg Twice Per Day) (View Sandimmune Review and Sandimmune Label ), DEXAMETHASONE (40mg Four Times Per Day) (View Dexamethasone Review and Dexamethasone Label ), AQUAPHOR (20mg Per Day) (View Aquaphor Review and Aquaphor Label ), ASPIRIN (100mg Per Day) (View Aspirin Review and Aspirin Label ), SODIUM HYDROGEN CARBONATE (View Sodium Hydrogen Carbonate Review and Sodium Hydrogen Carbonate Label ), CANDESARTAN CILEXETIL (8mg Twice Per Day) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), BONDRONAT (6mg Per Day) (View Bondronat Review and Bondronat Label ). Patient was hospitalized.

6705051-X | Visual Impairment
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: visual impairment on Apr 23, 2010 from JAPAN Additional patient health information: Male patient , 81 years of age, . Alkeran dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TAKEPRON (View Takepron Review and Takepron Label ), CLINORIL (View Clinoril Review and Clinoril Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6702451-9 | Pericarditis
Adverse event was reported on Apr 21, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: 250mg Per Day) was diagnosed with stem cell transplant and. Location: JAPAN , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: pericarditis. During the same period patient was treated with RITUXAN (700mg Per Day) (View Rituxan Review and Rituxan Label ), ENDOXAN (4400mg Per Day) (View Endoxan Review and Endoxan Label ), VEPESID (580mg Per Day) (View Vepesid Review and Vepesid Label ), DECADRON (40mg Per Day) (View Decadron Review and Decadron Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), GASTER D (20mg Per Day) (View Gaster D Review and Gaster D Label ), MUCOSTA (300mg Per Day) (View Mucosta Review and Mucosta Label ).

6696622-8 | Cardiac Failure, Disease Progression
on Apr 16, 2010 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). Patient had the following side effects: cardiac failure, disease progression. Alkeran dosage: 220mg Per Day. During the same period patient was treated with VEPESID (300mg Per Day) (View Vepesid Review and Vepesid Label ), CYMERIN (370mg Per Day) (View Cymerin Review and Cymerin Label ), CYLOCIDE (600mg Per Day) (View Cylocide Review and Cylocide Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), OXYCONTIN (10mg Per Day) (View Oxycontin Review and Oxycontin Label ), DUROTEP (View Durotep Review and Durotep Label ).

6690603-6 | Neurotoxicity, Overdose
on Apr 15, 2010 Male patient from JAPAN , 60 years of age, was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: neurotoxicity, overdose. Alkeran dosage: 400mgm2 Per Day.

6677480-4 | Cardiac Failure
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure on Apr 02, 2010 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with stem cell transplant and. Alkeran dosage: 220mg Per Day. During the same period patient was treated with VEPESID (300mg Per Day) (View Vepesid Review and Vepesid Label ), CYMERIN (370mg Per Day) (View Cymerin Review and Cymerin Label ), CYLOCIDE (600mg Per Day) (View Cylocide Review and Cylocide Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), OXYCONTIN (10mg Per Day) (View Oxycontin Review and Oxycontin Label ), DUROTEP (View Durotep Review and Durotep Label ).

6675493-X | Bone Sarcoma, Neoplasm Malignant
Adverse event was reported on Apr 02, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: ) was diagnosed with bone marrow transplant (What is bone marrow transplant?) and. Location: FRANCE , 14 years of age, Patient had the following side effects: bone sarcoma, neoplasm malignant. During the same period patient was treated with BUSULFEX (View Busulfex Review and Busulfex Label ), SAIZEN (View Saizen Review and Saizen Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ). Patient was hospitalized.

6675453-9 |
on Apr 06, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). . Alkeran dosage: 2mg Eight Times Per Day. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6643022-2 | Pericarditis
on Mar 11, 2010 Male patient from JAPAN , weighting 176.4 lb, was diagnosed with stem cell transplant and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: pericarditis. Alkeran dosage: 250mg Per Day. During the same period patient was treated with RITUXAN (700mg Per Day) (View Rituxan Review and Rituxan Label ), ENDOXAN (4400mg Per Day) (View Endoxan Review and Endoxan Label ), VEPESID (580mg Per Day) (View Vepesid Review and Vepesid Label ), DECADRON (40mg Per Day) (View Decadron Review and Decadron Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), FAMOTIDINE (20mg Per Day) (View Famotidine Review and Famotidine Label ), MUCOSTA (300mg Per Day) (View Mucosta Review and Mucosta Label ).

6643021-0 | Cardiac Failure
Patient was taking Alkeran (View Usage). Patient had the following side effects: cardiac failure on Mar 11, 2010 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with stem cell transplant and. Alkeran dosage: 220mg Per Day. During the same period patient was treated with VEPESID (300mg Per Day) (View Vepesid Review and Vepesid Label ), CYMERIN (370mg Per Day) (View Cymerin Review and Cymerin Label ), CYLOCIDE (600mg Per Day) (View Cylocide Review and Cylocide Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ), OXYCONTIN (10mg Per Day) (View Oxycontin Review and Oxycontin Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).